使用代谢组分析调查与骨质疏松症相关的因素
Madoka Sumi1, Takuro Okamura1, Shintaro Kajiyama1
1Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.
Journal of clinical biochemistry and nutrition
|June 13, 2025
概括
血清中氧酸和马龙酸水平可能表明2型糖尿病中骨质疏松症的风险. 这些代谢物和酸的较高水平可能预示着对teriparatide的治疗反应更好.
科学领域:
- 内分泌学 在内分泌学.
- 代谢学 代谢学 代谢学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 2型糖尿病 (T2DM) 与骨矿物质密度和质量降低有关,从而增加骨质疏松症的风险.
- 对血清代谢组与糖尿病骨质疏松症的联系的研究是有限的.
- 在T2DM中识别与骨质疏松症相关的因素对于有效管理至关重要.
研究的目的:
- 在T2DM患者中确定与骨质疏松症相关的血清代谢因子.
- 评估基线血清代谢物与骨密度和质量的变化在一年内之间的关系.
- 评估基线代谢物对特里巴胺治疗疗效的影响.
主要方法:
- 一项前性观察性研究,涉及91名T2DM患者 (67人没有骨质疏松症,24人患有骨质疏松症,接受了teriparatide治疗).
- 基线血清代谢组分析.
- 在基线和一年后评估骨矿物质密度和骨质量 (腰椎和靠近大腿骨).
- 血清代谢物和骨参数之间的相关性分析,包括治疗teriparatide的反应.
主要成果:
- 在一年的时间里,teriparatide治疗显著改善了腰椎骨的骨矿物密度和椎骨分数.
- 与未接受治疗的组相比,在治疗皮的组中,改善更为明显.
- 基线性酸酶,骨特异性性酸酶和马龙酸与骨密度负相关.
- 骨密度的变化与基线性酸盐酸酶,骨特异性性酸盐酸酶,酸和酸在特里巴化物组中正相关.
结论:
- 血清氧酸和马龙酸可能作为T2DM骨质疏松症的新生物标志物.
- 较高的基线血清氧化酸和酸水平可能会预测对特里巴类药物治疗的更有利反应.
- 代谢分析提供了糖尿病患者个性化骨质疏松症管理的潜力.
更多相关视频
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
2.3K
07:11Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
Published on: November 10, 2023
2.2K
相关概念视频
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
01:25Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
01:40Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K